Matches in SemOpenAlex for { <https://semopenalex.org/work/W4238742407> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4238742407 endingPage "vi35" @default.
- W4238742407 startingPage "vi35" @default.
- W4238742407 abstract "Abstract Young patients (< 40 years-old) with glioblastoma (GB) may carry IDH1/2 mutations or rarely, H3F3A/HIST1H3B mutations. Some instead harbor chromosome (chr) 7 gain, chr 10 loss, and EGFR amplification (amp). IDH1/2 mutations are associated with longer survival in contrast to H3F3A/HIST1H3B mutations. Novel reliable prognostic factors are needed in GB. Mitochondria (mt) are responsible for ATP production through oxidative phosphorylation. High mtDNA copy number (CN) has been associated with variable outcomes in cancer. The mtDNA-CN was assessed by RT Q-PCR in 66 GB from patients 18 to 40 years-old. Whole mitochondrial genome sequencing was performed in 18/66 GB. 17/66 (25.8%) cases harbored IDH1-R132H mutation; 29/66 (44%) had chr 7 gain/chr 10 loss and/or EGFRamp; 4/66 (6%) harbored H3F3A/HIST1H3B mutations. The remaining cases (24.2%) had no key genetic alterations. The mtDNA/nuclearDNA ratio was subdivided into groups: Low and High according to the median (mtDNA-CN median 194.9). 33 patients displayed a low ratio (≤ median) whereas 33 displayed a high ratio (> median). The overall survival in the High vs Low group was significantly longer in the whole cohort (Log-rank test, 31.8 vs 14.2 months, p= 0.019) and the chr7+/chr10-/EGFRamp subgroup (37.8 vs 12.1 months; p= 0.0117). There was still a trend towards longer survival in the High vs Low group within the other genetic subgroups (IDH-mutant; no genetic alteration) except for the H3-mutant GB (4 patients). Analyses on 232 patients 18 to 84 years-old showed that among patients < 56 years-old, the High group (58 cases) had a longer survival compared to the Low group (59 cases) (27.3 vs 15 months; p= 0.023). High mtDNA level is linked to oxidative metabolism (which decreases tumor aggressiveness) and cell differentiation. Increasing mtDNA-CN might induce tumor cell differentiation and slow disease progression. In conclusion, mtDNA-CN may be a novel prognostic biomarker in GB." @default.
- W4238742407 created "2022-05-12" @default.
- W4238742407 creator A5000418022 @default.
- W4238742407 creator A5004813149 @default.
- W4238742407 creator A5005202884 @default.
- W4238742407 creator A5015665453 @default.
- W4238742407 creator A5044332565 @default.
- W4238742407 creator A5059620448 @default.
- W4238742407 creator A5069138611 @default.
- W4238742407 creator A5075595989 @default.
- W4238742407 creator A5091708599 @default.
- W4238742407 date "2019-11-01" @default.
- W4238742407 modified "2023-10-17" @default.
- W4238742407 title "CBMT-11. HIGH MITOCHONDRIAL DNA COPY NUMBER IS ASSOCIATED WITH LONGER SURVIVAL IN YOUNG PATIENTS WITH GLIOBLASTOMA" @default.
- W4238742407 doi "https://doi.org/10.1093/neuonc/noz175.133" @default.
- W4238742407 hasPublicationYear "2019" @default.
- W4238742407 type Work @default.
- W4238742407 citedByCount "0" @default.
- W4238742407 crossrefType "journal-article" @default.
- W4238742407 hasAuthorship W4238742407A5000418022 @default.
- W4238742407 hasAuthorship W4238742407A5004813149 @default.
- W4238742407 hasAuthorship W4238742407A5005202884 @default.
- W4238742407 hasAuthorship W4238742407A5015665453 @default.
- W4238742407 hasAuthorship W4238742407A5044332565 @default.
- W4238742407 hasAuthorship W4238742407A5059620448 @default.
- W4238742407 hasAuthorship W4238742407A5069138611 @default.
- W4238742407 hasAuthorship W4238742407A5075595989 @default.
- W4238742407 hasAuthorship W4238742407A5091708599 @default.
- W4238742407 hasBestOaLocation W42387424071 @default.
- W4238742407 hasConcept C104317684 @default.
- W4238742407 hasConcept C121608353 @default.
- W4238742407 hasConcept C126322002 @default.
- W4238742407 hasConcept C127848430 @default.
- W4238742407 hasConcept C143998085 @default.
- W4238742407 hasConcept C153911025 @default.
- W4238742407 hasConcept C24586158 @default.
- W4238742407 hasConcept C2776194525 @default.
- W4238742407 hasConcept C501734568 @default.
- W4238742407 hasConcept C502942594 @default.
- W4238742407 hasConcept C54355233 @default.
- W4238742407 hasConcept C71924100 @default.
- W4238742407 hasConcept C86803240 @default.
- W4238742407 hasConceptScore W4238742407C104317684 @default.
- W4238742407 hasConceptScore W4238742407C121608353 @default.
- W4238742407 hasConceptScore W4238742407C126322002 @default.
- W4238742407 hasConceptScore W4238742407C127848430 @default.
- W4238742407 hasConceptScore W4238742407C143998085 @default.
- W4238742407 hasConceptScore W4238742407C153911025 @default.
- W4238742407 hasConceptScore W4238742407C24586158 @default.
- W4238742407 hasConceptScore W4238742407C2776194525 @default.
- W4238742407 hasConceptScore W4238742407C501734568 @default.
- W4238742407 hasConceptScore W4238742407C502942594 @default.
- W4238742407 hasConceptScore W4238742407C54355233 @default.
- W4238742407 hasConceptScore W4238742407C71924100 @default.
- W4238742407 hasConceptScore W4238742407C86803240 @default.
- W4238742407 hasIssue "Supplement_6" @default.
- W4238742407 hasLocation W42387424071 @default.
- W4238742407 hasLocation W42387424072 @default.
- W4238742407 hasOpenAccess W4238742407 @default.
- W4238742407 hasPrimaryLocation W42387424071 @default.
- W4238742407 hasRelatedWork W14505534 @default.
- W4238742407 hasRelatedWork W16645362 @default.
- W4238742407 hasRelatedWork W17414462 @default.
- W4238742407 hasRelatedWork W1872562 @default.
- W4238742407 hasRelatedWork W18786477 @default.
- W4238742407 hasRelatedWork W20515147 @default.
- W4238742407 hasRelatedWork W2287878 @default.
- W4238742407 hasRelatedWork W25971614 @default.
- W4238742407 hasRelatedWork W28795566 @default.
- W4238742407 hasRelatedWork W31221312 @default.
- W4238742407 hasVolume "21" @default.
- W4238742407 isParatext "false" @default.
- W4238742407 isRetracted "false" @default.
- W4238742407 workType "article" @default.